Telemonitoring in heart failure patients treated by cardiac resynchronisation therapy with defibrillator (CRT-D): the TELECART Study

• DOI: 10.1111/ijcp.12823
• Publication Date: 2016-06-13T08:02:44Z
• Authors: C. Sardu; M. Santamaria; M. R. Rizzo; M. Barbieri; M. di Marino; G. Paolisso; G. Santulli; R. Marfella
• Keywords: Heart Failure; Male; Medicine (all); 610; Monitoring, Ambulatory; Medical sciences; Medical telematics; Defibrillators, Implantable; 12. Responsible consumption; 3. Good health; Cardiac Resynchronization Therapy; Hospitalization; 03 medical and health sciences; 0302 clinical medicine; Heart failure--Patients; 616; Medical technology; Humans; Telemetry; Medicine; Female; Implantable cardioverter-defibrillators; Aged

Aim Telemonitoring (TM) is a safe and efficient monitoring system for internal cardioverter defibrillator device (ICD) recipients. TM has been used to track info on the clinical status of heart failure patients treated by ICD and/or cardiac resynchronisation therapy (CRT-D). The aim this study was investigate impact outcomes in population CRT-D with failure. Methods In multicentre, randomised study, chronic failure, New York Heart Association (NYHA) functional class II or III, left bundle branch block, severe ventricle ejection fraction reduction (LVEF < 35%) have identified screened. Results One hundred ninety-one receive either traditional ambulatory (control group) completed 12-month follow-up. Primary endpoints were all cause death, death hospital admission Secondary atrial fibrillation, sustained episodes, non-sustained self terminated ventricular tachyarrhythmia, tachycardia, shocks percentage responder patients. Univariate analysis following factors predicting hospitalisation: TM, age, kidney disease, hypercholesterolaemia, LVEF NYHA class. At multivariate analysis, only factor hospitalisation (hazard ratio 0.6, 0.42–0.79, 95% CI, p = 0.002), without affecting overall mortality deaths events. Conclusions Taken together, our data indicate importance CRT-D.